RS62030B1 - Kompozicije oligonukleotidni helatni kompleks-polipeptid i postupci - Google Patents
Kompozicije oligonukleotidni helatni kompleks-polipeptid i postupciInfo
- Publication number
- RS62030B1 RS62030B1 RS20210674A RSP20210674A RS62030B1 RS 62030 B1 RS62030 B1 RS 62030B1 RS 20210674 A RS20210674 A RS 20210674A RS P20210674 A RSP20210674 A RS P20210674A RS 62030 B1 RS62030 B1 RS 62030B1
- Authority
- RS
- Serbia
- Prior art keywords
- methods
- chelate complex
- polypeptide compositions
- oligonucleotide chelate
- oligonucleotide
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/2292—Thymosin; Related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
- A61K38/212—IFN-alpha
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
- A61K38/215—IFN-beta
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
- A61K38/217—IFN-gamma
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Endocrinology (AREA)
- Virology (AREA)
- Dermatology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Peptides Or Proteins (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201261648711P | 2012-05-18 | 2012-05-18 | |
US201261695035P | 2012-08-30 | 2012-08-30 | |
PCT/CA2013/050379 WO2013170386A1 (en) | 2012-05-18 | 2013-05-17 | Oligonucleotide chelate complex-polypeptide compositions and methods |
EP13791618.5A EP2849798B1 (en) | 2012-05-18 | 2013-05-17 | Oligonucleotide chelate complex-polypeptide compositions and methods |
Publications (1)
Publication Number | Publication Date |
---|---|
RS62030B1 true RS62030B1 (sr) | 2021-07-30 |
Family
ID=49581470
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RS20210674A RS62030B1 (sr) | 2012-05-18 | 2013-05-17 | Kompozicije oligonukleotidni helatni kompleks-polipeptid i postupci |
Country Status (34)
Country | Link |
---|---|
US (1) | US9492506B2 (sr) |
EP (1) | EP2849798B1 (sr) |
JP (1) | JP2015517504A (sr) |
KR (1) | KR102068109B1 (sr) |
CN (1) | CN104349793B (sr) |
AU (1) | AU2013262416B2 (sr) |
BR (1) | BR112014028654A2 (sr) |
CA (1) | CA2873529C (sr) |
CL (1) | CL2014003134A1 (sr) |
CO (1) | CO7131387A2 (sr) |
CR (1) | CR20140527A (sr) |
CY (1) | CY1124345T1 (sr) |
DK (1) | DK2849798T3 (sr) |
DO (1) | DOP2014000264A (sr) |
EA (1) | EA035967B1 (sr) |
EC (1) | ECSP14027694A (sr) |
ES (1) | ES2873844T3 (sr) |
HK (1) | HK1204279A1 (sr) |
HR (1) | HRP20210840T1 (sr) |
HU (1) | HUE054875T2 (sr) |
IL (1) | IL235548B (sr) |
LT (1) | LT2849798T (sr) |
MX (1) | MX346239B (sr) |
MY (1) | MY168778A (sr) |
NZ (1) | NZ703095A (sr) |
PH (1) | PH12014502551B1 (sr) |
PL (1) | PL2849798T3 (sr) |
PT (1) | PT2849798T (sr) |
RS (1) | RS62030B1 (sr) |
SG (1) | SG11201407599SA (sr) |
SI (1) | SI2849798T1 (sr) |
TW (1) | TWI635864B (sr) |
WO (1) | WO2013170386A1 (sr) |
ZA (1) | ZA201408674B (sr) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008141308A2 (en) | 2007-05-11 | 2008-11-20 | Adynxx, Inc. | Gene expression and pain |
JP6251247B2 (ja) | 2012-05-10 | 2017-12-20 | エーダイニクス インコーポレイテッド | 活性成分の送達のための製剤 |
MX361522B (es) | 2012-08-30 | 2018-12-10 | Replicor Inc | Uso de agentes farmacéuticos para la preparacion de un medicamento para el tratamiento de hepatitis b y hepatitis d. |
HRP20231400T1 (hr) | 2014-07-10 | 2024-02-16 | Replicor Inc. | Kelirani fosforotioirani polimeri nukleinskih kiselina, namijenjeni upotrebi u kombinaciji s inhibitorom hbv polimeraze u liječenju infekcija virusima hepatitisa b i hepatitisa d |
PT3180434T (pt) | 2014-08-15 | 2019-10-29 | Adynxx Inc | Chamarizes oligonucleotídicos para o tratamento da dor |
AU2019376079A1 (en) * | 2018-11-08 | 2021-05-27 | Aligos Therapeutics, Inc. | S-antigen transport inhibiting oligonucleotide polymers and methods |
US11166976B2 (en) | 2018-11-08 | 2021-11-09 | Aligos Therapeutics, Inc. | S-antigen transport inhibiting oligonucleotide polymers and methods |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2769114B2 (ja) * | 1993-10-29 | 1998-06-25 | サイクローン・ファーマシューティカルズ | ミニマルb型肝炎感染症治療用医薬組成物 |
UA78726C2 (en) * | 2001-11-01 | 2007-04-25 | Sciclone Pharmaceuticals Inc | Pharmaceutical composition of thymosin alpha 1 conjugated with polyethylene glycol, method for production, and method for treatment |
BR0314236A (pt) * | 2002-09-13 | 2005-08-09 | Replicor Inc | Formulação de oligonucleotìdeo, composição farmacêutica, kit, composto antiviral, preparação de oligonucleotìdeo e métodos para seleção de um oligonucleotìdeo antiviral para uso como um agente antiviral, para profilaxia ou tratamento de uma infecção viral em um paciente, para tratamento profilático de câncer causado por oncovìrus, para identificação de um composto que altera a ligação de um oligonucleotìdeo a pelo menos um componente viral, para purificação da ligação de oligonucleotìdeos a pelo menos um componente viral e para enriquecimento de oligonucleotìdeos a partir de um agrupamento de oligonucleotìdeos |
JP2006519235A (ja) * | 2003-02-26 | 2006-08-24 | インターミューン インコーポレイティッド | ポリエチレングリコール修飾インターフェロン組成物およびその使用方法 |
RU2006118359A (ru) * | 2003-10-27 | 2007-12-10 | Вертекс Фармасьютикалз Инкорпорейтед (Us) | Комбинации для лечения вирусного гепатита с (hcv) |
AU2005297376A1 (en) * | 2004-10-19 | 2006-04-27 | Replicor Inc. | Antiviral oligonucleotides |
WO2007022642A2 (en) * | 2005-08-25 | 2007-03-01 | Replicor Inc. | Anti-inflammatory molecules and their uses |
US20090215873A1 (en) * | 2005-09-29 | 2009-08-27 | Andrew Vaillant | Therapeutic Molecules and their Uses |
US7776818B2 (en) * | 2005-09-29 | 2010-08-17 | S-Cell Biosciences, Inc. | Methods to treat T-cell disorders using TISF |
GB0715383D0 (en) * | 2007-08-08 | 2007-09-19 | Asterion Ltd | Interferon |
WO2009065181A1 (en) * | 2007-11-21 | 2009-05-28 | Apollo Life Sciences Limited | Nanostructures suitable for delivery of agents |
US20090238772A1 (en) | 2007-12-13 | 2009-09-24 | Alnylam Pharmaceuticals, Inc. | Methods and compositions for prevention or treatment of rsv infection |
US8404659B2 (en) | 2008-03-07 | 2013-03-26 | Santaris Pharma A/S | Pharmaceutical compositions for treatment of MicroRNA related diseases |
KR101704988B1 (ko) * | 2009-05-28 | 2017-02-08 | 큐알엔에이, 인크. | 항바이러스 유전자에 대한 천연 안티센스 전사체의 억제에 의한 항바이러스 유전자 관련된 질환의 치료 |
ES2651308T3 (es) * | 2009-10-16 | 2018-01-25 | Glaxo Group Limited | Inhibidores antisentido de HBV |
PL2605794T3 (pl) * | 2010-08-20 | 2017-01-31 | Replicor Inc. | Chelatowe kompleksy oligonukleotydów |
MX361522B (es) | 2012-08-30 | 2018-12-10 | Replicor Inc | Uso de agentes farmacéuticos para la preparacion de un medicamento para el tratamiento de hepatitis b y hepatitis d. |
-
2013
- 2013-05-17 PL PL13791618T patent/PL2849798T3/pl unknown
- 2013-05-17 KR KR1020147035252A patent/KR102068109B1/ko active IP Right Grant
- 2013-05-17 SG SG11201407599SA patent/SG11201407599SA/en unknown
- 2013-05-17 RS RS20210674A patent/RS62030B1/sr unknown
- 2013-05-17 NZ NZ703095A patent/NZ703095A/en unknown
- 2013-05-17 DK DK13791618.5T patent/DK2849798T3/da active
- 2013-05-17 PT PT137916185T patent/PT2849798T/pt unknown
- 2013-05-17 CA CA2873529A patent/CA2873529C/en active Active
- 2013-05-17 CN CN201380026009.3A patent/CN104349793B/zh active Active
- 2013-05-17 LT LTEP13791618.5T patent/LT2849798T/lt unknown
- 2013-05-17 US US13/896,510 patent/US9492506B2/en active Active
- 2013-05-17 ES ES13791618T patent/ES2873844T3/es active Active
- 2013-05-17 MX MX2014014021A patent/MX346239B/es active IP Right Grant
- 2013-05-17 WO PCT/CA2013/050379 patent/WO2013170386A1/en active Application Filing
- 2013-05-17 EA EA201401278A patent/EA035967B1/ru unknown
- 2013-05-17 EP EP13791618.5A patent/EP2849798B1/en active Active
- 2013-05-17 JP JP2015511877A patent/JP2015517504A/ja active Pending
- 2013-05-17 HU HUE13791618A patent/HUE054875T2/hu unknown
- 2013-05-17 AU AU2013262416A patent/AU2013262416B2/en active Active
- 2013-05-17 MY MYPI2014003189A patent/MY168778A/en unknown
- 2013-05-17 SI SI201331881T patent/SI2849798T1/sl unknown
- 2013-05-17 TW TW102117594A patent/TWI635864B/zh active
- 2013-05-17 BR BR112014028654A patent/BR112014028654A2/pt active Search and Examination
-
2014
- 2014-11-06 IL IL235548A patent/IL235548B/en active IP Right Grant
- 2014-11-14 PH PH12014502551A patent/PH12014502551B1/en unknown
- 2014-11-18 CR CR20140527A patent/CR20140527A/es unknown
- 2014-11-18 CL CL2014003134A patent/CL2014003134A1/es unknown
- 2014-11-18 EC ECIEPI201427694A patent/ECSP14027694A/es unknown
- 2014-11-18 DO DO2014000264A patent/DOP2014000264A/es unknown
- 2014-11-19 CO CO14254322A patent/CO7131387A2/es unknown
- 2014-11-25 ZA ZA2014/08674A patent/ZA201408674B/en unknown
-
2015
- 2015-05-21 HK HK15104859.5A patent/HK1204279A1/xx unknown
-
2021
- 2021-05-26 HR HRP20210840TT patent/HRP20210840T1/hr unknown
- 2021-05-31 CY CY20211100467T patent/CY1124345T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2836212A4 (en) | NOVEL COMPOSITIONS AND METHOD | |
ZA201408594B (en) | Xylitol-based anti-mucosal compositions and related methods and compositions | |
HK1206259A1 (en) | Oligonucleotide chelate complex methods | |
HK1216250A1 (zh) | '- '-羥基-二氫麥角胺化合物及組合物 | |
ZA201408674B (en) | Oligonucleotide chelate complex-polypeptide compositions and methods | |
EP2804611A4 (en) | COMPOSITIONS FROM CHITOSAN | |
EP2852602A4 (en) | COMPOSITIONS AND METHODS FOR CONJUGATING OLIGONUCLEOTIDES | |
GB201315350D0 (en) | Methods and compositions | |
GB201315347D0 (en) | Methods and compositions | |
EP2874641A4 (en) | COMPOSITIONS INCREASING THE GLUTATHION RATE AND USES THEREOF | |
EP2879670A4 (en) | ANTIBACTERIAL COMPOSITIONS AND METHOD | |
GB201210800D0 (en) | Compositions | |
GB201209244D0 (en) | Compositions | |
GB201201287D0 (en) | Compositions | |
EP2931280A4 (en) | METHOD AND COMPOSITIONS FOR INHIBITING CNKSR1 | |
ZA201308892B (en) | Compositions and methods | |
EP2766357A4 (en) | MESOBILIVERDINE COMPOSITIONS AND METHOD THEREFOR | |
EP2834635A4 (en) | COMPOSITIONS WITH A HEPARINE ACCUMULATIVE AND METHOD THEREFOR | |
EP2926813A4 (en) | METFORMIN-Orlistat COMPOSITIONS | |
GB201209187D0 (en) | Compositions | |
GB201209189D0 (en) | Compositions | |
GB201116340D0 (en) | Compositions and methods | |
GB201204103D0 (en) | Compositions | |
GB201203084D0 (en) | Compositions | |
GB201203083D0 (en) | Compositions |